High-Quality Crospovidone XL Type A: A Versatile Pharmaceutical Intermediate for Enhanced Drug Delivery
Discover the power of Crospovidone XL Type A, a premium pharmaceutical intermediate that revolutionizes drug formulation. Enhance dissolution, improve bioavailability, and streamline your manufacturing processes with this advanced superdisintegrant.
Get a Quote & SampleProduct Core Value
Crospovidone XL Type A
As a leading supplier in China, we provide high-quality Crospovidone XL Type A, a vital pharmaceutical intermediate. This cross-linked polyvinylpyrrolidone (PVP) is expertly manufactured to serve as a superior superdisintegrant, dramatically improving the disintegration and dissolution of active pharmaceutical ingredients (APIs). Its unique properties enable faster drug release, leading to enhanced bioavailability and therapeutic efficacy for a wide range of pharmaceutical applications.
- Leverage Crospovidone XL Type A for rapid disintegration and dissolution, essential for improving the bioavailability of poorly soluble APIs.
- Experience the benefits of using this cross-linked polyvinylpyrrolidone pharmaceutical excipient as a reliable agent in complex drug formulations.
- Streamline your manufacturing with a product designed for direct compression and wet granulation processes, supporting efficient production cycles.
- Ensure product stability and efficacy with a pharmaceutical intermediate boasting a 2-year shelf life, maintaining its performance over time.
Product Advantages
Enhanced Dissolution Rates
Utilize Crospovidone XL Type A to achieve significantly faster disintegration and dissolution of your pharmaceutical products, a key factor in effective drug delivery.
Improved Bioavailability
This pharmaceutical intermediate plays a crucial role in enhancing the bioavailability of APIs by increasing their surface area exposure to bodily fluids, leading to better therapeutic outcomes.
Manufacturing Process Simplification
Crospovidone XL Type A is an excellent choice for direct compression formulations and wet granulation processes, simplifying tablet manufacturing and reducing production complexity.
Key Applications
Pharmaceutical Tablets
As a premier pharmaceutical intermediate, Crospovidone XL Type A is essential for formulating tablets that require rapid disintegration and improved drug release profiles.
Orally Disintegrating Tablets (ODTs)
This superdisintegrant is ideal for ODTs, promoting quick breakdown upon contact with saliva, thus aiding patients who have difficulty swallowing.
Capsules
In capsule formulations, Crospovidone XL Type A helps ensure timely release of the active pharmaceutical ingredients, contributing to consistent therapeutic effects.
Direct Compression
Facilitates the direct compression of tablets, offering a more efficient and cost-effective manufacturing pathway for pharmaceutical companies.